Vantage Consulting Group’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $1.56M | Sell |
|
|||||
|
2023
Q2 | $20M | Sell |
|
|||||
|
2023
Q1 | $36.8M | Hold |
|
|||||
|
2022
Q4 | $35.5M | Hold |
|
|||||
|
2022
Q3 | $41.1M | Sell |
|
|||||
|
2022
Q2 | $44.2M | Sell |
|
|||||
|
2022
Q1 | $106M | Sell |
|
|||||
|
2021
Q4 | $183M | Sell |
|
|||||
|
2021
Q3 | $284M | Sell |
|
|||||
|
2021
Q2 | $381M | Buy |
|
|||||
|
2021
Q1 | $380M | Sell |
|
|||||
|
2020
Q4 | $1.07B | Buy |
|